CDC and FDA issue joint pause on Johnson & Johnson coronavirus vaccine
By Amit SyalOn Tuesday morning, the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration issued a joint statement calling for a pause on the administration of the Johnson & Johnson (Janssen) coronavirus vaccine. The call came after the two agencies reviewed data involving six reported U.S. cases of a rare and severe type of blood clot in individuals who received the vaccine. Read more